DCOY · Decoy Therapeutics Inc.
$4.03
-0.01 (-0.25%)
At close · Jul 29
Going-concern doubt
— flagged May 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The lack of revenue from product sales to date and recurring losses from operations since its inception raise substantial doubt as to the Company's ability to continue as a going concern. Based on Decoy's expected cash requirements, Decoy believes that there is substantial doubt that its existing cash and cash equivalents, will be sufficient to fund its operations through one year from the financial statements' issuance date.”View the 10-Q filed May 8, 2026
Market Cap
$2.14M
Shares
531,968
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 116,893 | $9.59 | $1,121,004 |
| 2026-06-26 | 193 | $5.90 | $1,139 |
| 2026-06-24 | 11 | $6.00 | $66 |
| 2026-06-15 | 624 | $5.93 | $3,700 |
| 2026-06-10 | 112 | $5.51 | $617 |
| 2026-06-08 | 118 | $6.61 | $780 |
| 2026-06-03 | 2,024 | $8.61 | $17,427 |
| 2026-06-01 | 376 | $8.90 | $3,346 |
| 2026-05-29 | 2,009 | $7.91 | $15,891 |
| 2026-05-28 | 35 | $8.05 | $282 |
| 2026-05-27 | 701 | $7.63 | $5,349 |
| 2026-05-22 | 129 | $6.26 | $808 |
| 2026-05-21 | 99 | $5.52 | $546 |
| 2026-05-20 | 109 | $5.42 | $591 |
| 2026-05-18 | 85 | $4.41 | $375 |
| 2026-05-07 | 1,129 | $6.01 | $6,785 |
| 2026-04-30 | 875 | $5.59 | $4,891 |
Showing 1–17 of 17 settlements